Horizon Discovery Group Plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Horizon Discovery Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2007
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:280
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Horizon Discovery Group Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Horizon Discovery Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Horizon Discovery Group Plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Horizon Discovery Group Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Horizon Discovery Group Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Horizon Discovery Group Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Horizon Discovery Group Plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Horizon Discovery Group Plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Horizon Discovery Group Plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 19
Partnership – Overview 19
Partnership – Deal reports 20
CAPITAL RAISING 251
Capital Raising – Overview 251
Capital Raising – Deal reports 252
PRIVATE EQUITY & OWNERSHIP 268
Private Equity and Ownership – Deal reports 268
APPENDIX 270
Contact Us 270
About MarketLine Financial Deals Database 270
Deal Definition and Methodology 272
About MarketLine 279

List of Tables
Table 1: Horizon Discovery Group Plc M&A volume and value trend (2014-YTD2018)
Table 2: Horizon Discovery Group Plc M&A activity by geography (2014-YTD2018)
Table 3: Horizon Discovery Group Plc partnership volume and value trend (2014-YTD2018)
Table 4: Horizon Discovery Group Plc partnership trend by key deal type (2014-YTD2018)
Table 5: Horizon Discovery Group Plc capital raising volume and value trend (2014-YTD2018)
Table 6: Horizon Discovery Group Plc capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Horizon Discovery Group Plc M&A volume and value trend (2014-YTD2018)
Figure 2: Horizon Discovery Group Plc M&A activity by geography (2014-YTD2018)
Figure 3: Horizon Discovery Group Plc partnership volume and value trend (2014-YTD2018)
Figure 4: Horizon Discovery Group Plc partnership trend by key deal type (2014-YTD2018)
Figure 5: Horizon Discovery Group Plc capital raising volume and value trend (2014-YTD2018)
Figure 6: Horizon Discovery Group Plc capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Horizon Discovery Group Plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務分析
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Presidio Inc (PSDO):企業の財務・戦略的SWOT分析
    Presidio Inc (PSDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Heathrow Airport Holdings Limited:企業の戦略・SWOT・財務分析
    Heathrow Airport Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Heathrow Airport Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Crocs, Inc.:企業の戦略・SWOT・財務情報
    Crocs, Inc. - Strategy, SWOT and Corporate Finance Report Summary Crocs, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fortis Inc (FTS):企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • ABF Ingredients Ltd:企業の戦略・SWOT・財務情報
    ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report Summary ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ArQule Inc (ARQL)-製薬・医療分野:企業M&A・提携分析
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …
  • Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix …
  • Banco Santander-Chile:企業の戦略・SWOT・財務情報
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • Alteogen Inc (196170):製薬・医療:M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • Sapience Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sapience Therapeutics Inc (Sapience) is a preclinical-stage biotechnology company that focuses on developing novel therapeutics for major unmet medical needs with special emphasis on high mortality cancers. The company offers peptides that act at the level of transcriptional regulation of on …
  • Indianola Municipal Utilities:発電所・企業SWOT分析
    Indianola Municipal Utilities - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • The Mauritius Commercial Bank Limited:企業の戦略・SWOT・財務情報
    The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Chongqing Lummy Pharmaceutical Co Ltd (300006):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Lummy Pharmaceutical Co Ltd (Lummy) is a pharmaceutical company that provides pharmaceutical ingredients and drugs and related products. The company’s products include antibacterial drugs, antifungal drugs, tumor drugs, immune system agents, blood system agents, cardiovascular syst …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆